Drugs associated with drug-induced pancreatitis: focus on rarely discussed drugs-Reference-Cited by-同舟云学术

Drugs associated with drug-induced pancreatitis: focus on rarely discussed drugs

Published:2021-10-19 Issue:29 Volume:1 Page:33-39
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Filippova A. V.¹^ORCID,Pavleeva E. E.²^ORCID,Ostroumova O. D.³^ORCID

Affiliation:

1. Russian Medical Academy for Continuing Professional Education

2. Moscow State University of Medicine and Dentistry n.a. A.I. Evdokimov

3. Russian Medical Academy for Continuing Professional Education; First Moscow State Medical University n.a. I.M. Sechenov

Abstract

More than 500 medicines are included in the database of the World Health Organization as drugs that can cause acute inflammation of the pancreas. Drug-induced acute pancreatitis develops against the background of taking many medications (statins, antitumor drugs, drugs for the treatment of diseases of the gastrointestinal tract, analgesics and anti-inflammatory drugs, antimicrobial, antiparasitic and antiviral drugs, drugs for the treatment of tuberculosis, diseases of the central nervous system, estrogens, calcium preparations, etc.) from different classes, while the clinical picture does not differ from pancreatitis of other etiology. Based on this, it is worth paying attention to the reasons that contributed to the development of this pathology. Therefore, one of the main principles of the diagnosis of drug-induced pancreatitis is a thorough collection of a pharmacological history. If you suspect that pancreatitis was caused by a drug, you should immediately stop using it and start traditional therapeutic treatment.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference111 articles.

1. Eland IA, van Puijenbroek EP, Sturkenboom MJCM, Wilson JHP, Stricker BH. Drug-Associated Acute Pancreatitis: Twenty-One Years of Spontaneous Reporting in The Netherlands. American Journal of Gastroenterology. 1999; 94 (9): 2417–2422. DOI: 10.1111/j.1572–0241.1999.01367.x.

2. Dolin R, Lambert JS, Morse GD, Reichman RC et al. 2′,3′-Dideoxyinosine in Patients with AIDS or AIDS-Related Complex. Reviews of Infectious Diseases. 1990; 12 (5): 540–551. DOI: 10.1093/clinids/12.Supplement_5.S540.

3. Yarchoan R, Mitsuya H, Pluda JM et al. The National Cancer Institute Phase I study of 2’,3’-dideoxyinosine administration in adults with AIDS or AIDS-related complex: analysis of activity and toxicity profiles. Rev Infect Dis. 1990; 12 (5): 522–33. DOI: 10.1093/clinids/12.supplement_5.s522.

4. Wolfe D, Kanji S, Yazdi F et al. Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations. PLoS One. 2020; 15 (4): e0231883. DOI: 10.1371/journal.pone.0231883.

5. NIAID updates dideoxyinosine toxicity profile, suggests ways to reduce risk of pancreatitis. Clin Pharm. 1990; 9 (11): 832, 838. DOI: 10.2165/00128413–199007540–00015.